News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

InvisiDerm Healthcare Completes Successful Clinical Trial of Transdermal Delivery, Discusses Medical Applications



11/12/2012 7:40:08 AM

PASADENA, Calif., Nov. 12, 2012 (GLOBE NEWSWIRE) -- InvisiDerm Healthcare ("InvisiDerm"), developer and manufacturer of noninvasive gas and drug delivery methods, announced the completion of the initial clinical study using its innovative D`Oxyva® transdermal delivery platform. The company has submitted the results to a peer-reviewed medical journal for publication in Q1 2013.

Read at GlobeNewswire


comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES